Follicular lymphoma: recent and emerging therapies, treatment strategies, and remaining unmet needs is organized by Society for Translational Oncology (STO).
Release Date: 11/22/2019
Expiry Date: 11/22/2021
Accreditation:
The Society for Translational Oncology designates this journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit™.
Learning objectives:
• Describe therapeutic options and new developments for first-line treatment in FL.
• Discuss therapeutic options and new developments for untreated and relapsed FL.
• Distinguish between the treatment of early versus later- or multiply-relapsed FL.
• Describe the latest advances in use of prognostic tools for risk stratification in FL.
Additional details will be posted as soon as information is available.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved